Physician profile
Michele A Mathieu
NPI 1811072986
$575.26
in general payments reported to CMS, 2019-2025
15 companies · $168 in 2025
The $168 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $34.85 · 2022: $24.99 · 2023: $91.48 · 2024: $20.03 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $279.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $123.10 | 2019-2025 | Gardasil 9, Vaxelis, M-M-R II |
| Glaxosmithkline, LLC. | $67.23 | 2019-2020 | |
| Exeltis, USA INC. | $57.69 | 2025 | Slynd |
| Neos Therapeutics, LP | $37.97 | 2019 | |
| Collegium Pharmaceutical, INC. | $37.37 | 2025 | Jornay Pm |
| Kaleo, INC. | $33.43 | 2023 | Auvi-Q |
| Tris Pharma INC | $30.09 | 2019 | |
| Dermira, INC. | $29.36 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $25.33 | 2025 | Neffy |
| Neurelis, INC. | $24.99 | 2022 | |
| Alk-Abello, INC | $24.52 | 2025 | Neffy |
| Amneal Pharmaceuticals LLC | $23.06 | 2019 | |
| Ironshore Pharmaceuticals INC. | $23.03 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $21.97 | 2023 | Flumist Quadrivalent |
| Shire North American Group INC | $16.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Mathieu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.